Significant increase in volume has been observed in Venus Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.6 pts more than Nifty Microcap 250 and 6.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NSE observed a significant increase in trading volume in Venus Remedies Limited shares. As a routine safeguard, the exchange has written to the company asking for any relevant information that could explain the unusual activity. The company has not yet responded, and the market is awaiting its reply. Until the company clarifies, the reason behind the volume surge remains unknown. Investors should watch for the company's response, which could shed light on whether the move is driven by any corporate development.
Short-term volatility in the stock is likely as traders wait for clarity. If the company confirms no material information, the volume spike could fizzle out and the stock may give back gains. Investors should avoid making decisions based purely on the price/volume move without verified information.